Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients

T. Kerbusch; A.D.R. Huitema; R.A.A. Mathot; J.H. Beijnen

Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients

T. Kerbusch
, A.D.R. Huitema
, R.A.A. Mathot
, J.H. Beijnen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	53-61
Number of pages	9
Journal	Cancer Chemotherapy and Pharmacology
Volume	48
Publication status	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{c5831b8df6f444ba892af6a02176fdbc,

title = "Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients",

author = "T. Kerbusch and A.D.R. Huitema and R.A.A. Mathot and J.H. Beijnen",

year = "2001",

language = "Undefined/Unknown",

volume = "48",

pages = "53--61",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients

AU - Kerbusch, T.

AU - Huitema, A.D.R.

AU - Mathot, R.A.A.

AU - Beijnen, J.H.

PY - 2001

Y1 - 2001

M3 - Article

SN - 0344-5704

VL - 48

SP - 53

EP - 61

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

ER -